These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 12297808
1. Community-based treatment of acute uncomplicated bacterial rhinosinusitis with gatifloxacin. Sher LD, Poole MD, Von Seggern K, Wikler MA, Nicholson SC, Pankey GA. Otolaryngol Head Neck Surg; 2002 Sep; 127(3):182-9. PubMed ID: 12297808 [Abstract] [Full Text] [Related]
3. Multicenter evaluation of the efficacy and safety of gatifloxacin in Mexican adult outpatients with respiratory tract infections. Casillas JL, Rico G, Rodríguez-Parga D, Mascareño A, Rangel-Frausto S. Adv Ther; 2000 Sep; 17(6):263-71. PubMed ID: 11317829 [Abstract] [Full Text] [Related]
7. An open multicenter study of the use of gatifloxacin for the treatment of non-complicated acute bacterial rhinosinusitis in adults. Weckx LL, Campos CA, Sakano E, Pignatari SS, Figueiredo CR. Braz J Infect Dis; 2005 Apr; 9(2):162-8. PubMed ID: 16127593 [Abstract] [Full Text] [Related]
12. [The pathogen spectrum of acute bacterial rhinitis/sinusitis and antibiotic resistance]. Fickweiler U, Fickweiler K. HNO; 2005 Aug; 53(8):735-40. PubMed ID: 15702353 [Abstract] [Full Text] [Related]
13. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010]. Wang H, Liu YL, Chen MJ, Xu YC, Sun HL, Yang QW, Hu YJ, Cao B, Chu YZ, Liu Y, Zhang R, Yu YS, Sun ZY, Zhuo C, Ni YX, Hu BJ. Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967 [Abstract] [Full Text] [Related]
14. An open label, multicenter, non-comparative study of the efficacy and safety of oral gatifloxacin in the treatment of community-acquired pneumonia: a Brazilian study in five centers. Nicodemo AC. Braz J Infect Dis; 2003 Feb; 7(1):62-8. PubMed ID: 12807692 [Abstract] [Full Text] [Related]
15. Current management of acute bacterial rhinosinusitis and the role of moxifloxacin. Anon JB. Clin Infect Dis; 2005 Jul 15; 41 Suppl 2(Suppl 2):S167-76. PubMed ID: 15942883 [Abstract] [Full Text] [Related]
16. Gatifloxacin: a review of its use in the management of bacterial infections. Perry CM, Ormrod D, Hurst M, Onrust SV. Drugs; 2002 Jul 15; 62(1):169-207. PubMed ID: 11790160 [Abstract] [Full Text] [Related]
17. Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management. Anon JB. Paediatr Drugs; 2003 Jul 15; 5 Suppl 1():25-33. PubMed ID: 14632103 [Abstract] [Full Text] [Related]
18. Implications of TeqCES: efficacy and safety of gatifloxacin in community-acquired pneumonia. Mandell LA, Jones RN. Diagn Microbiol Infect Dis; 2002 Sep 15; 44(1):127-8. PubMed ID: 12376042 [No Abstract] [Full Text] [Related]
19. Efficacy/safety of amoxicillin/clavulanate in adults with bacterial rhinosinusitis. Anon JB, Berkowitz E, Breton J, Twynholm M. Am J Otolaryngol; 2006 Sep 15; 27(4):248-54. PubMed ID: 16798401 [Abstract] [Full Text] [Related]
20. Safety and efficacy of gatifloxacin in community-acquired pneumonia: rationale for the Tequin Clinical Experience Study (TeqCES). Mandell LA. Diagn Microbiol Infect Dis; 2002 Sep 15; 44(1):65-7. PubMed ID: 12376034 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]